Skip to main content

Highlights

  1. 1
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    PMID: 37031718DOIFirst author15 citations
  2. 2
    Journal of hepatology · 2022
    PMID: 35643203DOIFirst author48 citations
  3. 3
    Hepatology communications · 2022
    PMID: 35748104PMCID: PMC9426407DOISenior author21 citations

Publications

101 publications

Active

2 grants
  • PI
    Targeting Nonalcoholic Fatty Liver Disease during the reproductive period to improve women's health outcomes
    National Institute of Diabetes and Digestive and Kidney Diseases · 2025–2029
    R01DK139189-02
  • PI
    Nonalcoholic fatty liver disease, associated lipidomic changes, and preeclampsia risk
    National Heart, Lung, and Blood Institute · 2025–2027Career
    K23HL163486-03

Clinical research

10 studies

Active

9 studies
  • PI
    Prevalence and implications of cholestatic gene mutations in intrahepatic cholestasis of pregnancy among a diverse U.S. cohort: a prospective study in a diverse health setting with 8000+ annual pregnancy deliveries
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
  • PI
    Beyond viral load: understanding how mental health and patient perspective shape hepatitis B treatment engagement
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
  • PI
    Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta
    PHASE1; PHASE2 · Gilead Sciences, Inc. · OPEN TO ACCRUAL (as of 2026)
    Chronic Hepatitis Delta
    NCT07096193
  • PI
    A Pragmatic Approach to Pruritus Screening: A Descriptive Observational Study Using a Simplified Clinical Protocol
    New York Presbyterian Brooklyn Methodist Hospital · OPEN TO ACCRUAL (as of 2026)
  • PI
    Prevalence and implications of cholestatic gene mutations in suspected intrahepatic cholestasis of pregnancy among a diverse U.S. cohort: a prospective study in a diverse health setting with 8000+ annual pregnancy deliveries
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
  • PI
    Expanded Access Treatment Protocol for Bulevirtide
    Gilead Sciences, Inc. · OPEN TO ACCRUAL (as of 2025)
    Chronic Hepatitis Delta Virus Infection
    NCT06780579
  • PI
    Evaluating the prevalence of metabolic dysfunction associated steatotic liver disease (MASLD) During Pregnancy
    National Center for Complementary and Integrative Health/NIH/DHHS · OPEN TO ACCRUAL (as of 2025)
  • PI
    Evaluating prevalence, predictors and outcomes of Liver Diseases Unique to Pregnancy
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
  • PI
    Characterizing Epidemiology, Natural History and Management of Patients with Chronic Viral Hepatitis Infection
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
Completed & closed trials (1)
  • PI
    A Global, Randomized, Open-label, Multicenter, Phase 2b/3 Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-1)
    PHASE2; PHASE3 · Mirum Pharmaceuticals, Inc. · CLOSED TO ACCRUAL (as of 2026)
    Chronic Hepatitis D Infection
    NCT06907290

Media highlights

4 clips

External relationships

Advisory/Scientific Board Member

Gilead Sciences, Inc. · Ipsen Pharma S.A.S. · Mirum Pharmaceuticals, Inc.

Other Interest

Gilead Sciences, Inc.